| 000 | 01352 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511181250.0 | ||
| 264 | 0 | _c19920914 | |
| 008 | 199209s 0 0 eng d | ||
| 022 | _a0362-5664 | ||
| 024 | 7 |
_a10.1097/00002826-199201001-00013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBischoff, S | |
| 245 | 0 | 0 |
_aCan brain region-selective dopamine (DA) receptor blockers preferentially act on schizophrenia subtypes? _h[electronic resource] |
| 260 |
_bClinical neuropharmacology _c1992 |
||
| 300 |
_a23A-24A p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzazepines _xpharmacology |
| 650 | 0 | 4 |
_aBinding, Competitive _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aDopamine Antagonists |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
| 650 | 0 | 4 |
_aSchizophrenia _xclassification |
| 650 | 0 | 4 |
_aSpiperone _xpharmacology |
| 700 | 1 | _aBruinink, A | |
| 700 | 1 | _aGunst, F | |
| 700 | 1 | _aKrauss, J | |
| 700 | 1 | _aSchaub, M | |
| 700 | 1 | _aVassout, A | |
| 700 | 1 | _aMaitre, L | |
| 773 | 0 |
_tClinical neuropharmacology _gvol. 15 Suppl 1 Pt A _gp. 23A-24A |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002826-199201001-00013 _zAvailable from publisher's website |
| 999 |
_c1360527 _d1360527 |
||